drugset
drugset / Trial / NCT00653549

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

NCT00653549 ↗

Phase 1 Completed 26 enrolled Par Pharmaceutical, Inc. Anapharm · collab
RandomizedCrossoverOpen-label

Summary

To compare the single-dose bioavailability of Torsemide tablets with Demadex

Timeline

Start
2001-04
Primary completion
2001-05
Completion
2001-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Torsemide Other / unclassified 20 mg —

Indications

No indication recorded.